Treatment of Advanced Gastrointestinal Cancer With Genetically Modified Autologous Mesenchymal Stem Cells - TREAT-ME-1 - A Phase I, First in Human, First in Class Trial

Oncotarget - United States
doi 10.18632/oncotarget.20964
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

First-In-Human Phase 1 Trial of Agarose Beads Containing Murine RENCA Cells in Advanced Solid Tumors

Cancer Growth and Metastasis
2016English

A Phase I First-In-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients With Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Anti-Tumour Activity of a First-In-Class Agent NUC-1031 in Patients With Advanced Cancer: Results of a Phase I Study

British Journal of Cancer
Cancer ResearchOncology
2018English

First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2014English

OA10.06 a First-In-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A First-In-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination With Erlotinib in Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

First‐in‐human Phase I Study of E7090, a Novel Selective FGFR Inhibitor, in Patients With Advanced Solid Tumors

Cancer Science
Cancer ResearchMedicineOncology
2020English

Mesenchymal Stem Cells Expanded in Vitro With Human Serum for the Treatment of Acute and Chronic Graft-Versus-Host Disease: Results of a Phase I/Ii Clinical Trial

Haematologica
Hematology
2011English

Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy